Thermo Fisher Enters into New $1.5B Credit Agreement | GenomeWeb

NEW YORK (GenomeWeb News) – Thermo Fisher Scientific said after the close of the market on Friday that it has entered into a new $1.5 billion credit agreement, replacing the existing $1 billion revolving credit agreement.

The new agreement is a five-year senior unsecured revolving facility, Thermo Fisher said in a document filed with the US Securities and Exchange Commission. Thermo Fisher entered into the new agreement on July 25.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: tool to discover copy number variants, single-nucleus RNA sequencing study of myoblasts, and more.

A study of Tasmanian devil genomes suggests they are evolving resistance to devil facial tumor disease.

Theranos has withdrawn its request for emergency clearance of a Zika virus blood test, according to the Wall Street Journal.

An assistant professor who was fired from Mount Sinai School of Medicine has allegedly shot the school's dean, the New York Times reports.